ArticleCancer medicine2023

Identifying HER2 from serum-derived exosomes in advanced gastric cancer as a promising biomarker for assessing tissue HER2 status and predicting the efficacy of trastuzumab-based therapy.

Qian Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.